Search - tctmd.com

Displaying 81 - 100 of 105

Sort: Relevancy | Date

News Daily News

As Stroke Rates Fall, Questions Mount for Embolic Protection Devices in TAVR

Michael O'Riordan

March 14, 2016

News Conference News TCT 2015

MISTRAL-C: Cerebral Protection in TAVR May Reduce New Lesions

October 14, 2015

News Industry News

First US Multi-center Study Finds Unprotected TAVR Procedures Produce New Brain Lesions in Nearly All Cases

October 14, 2015

News Daily News

Cerebral Embolization Greater When Valvuloplasty Not Done Before TAVR

Todd Neale

September 21, 2015

News Daily News

Mayor Embolización Cerebral Cuando Antes de la TAVR No se realiza una Valvuloplastia

Todd Neale

September 21, 2015

News Conference News EuroPCR 2015

DEFLECT III: 30-Day Results Show Successful, Safe TAVR With Novel Neuroprotection Device

Yael L. Maxwell

May 20, 2015

News Daily News

Study Provides Insight Into Cerebral Embolization During TAVR

April 29, 2015

News Conference News ACC 2015

DEFLECT III: TAVR Neuroprotection Device Safely Reduces Lesion Volume

Yael L. Maxwell

March 16, 2015

Presentation TCT 2014

CLEAN-TAVI: A Prospective, Randomized Trial of Cerebral Embolic Protection in High-Risk Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Presenter: Patrick W. Serruys, David J. Cohen, Axel Linke

September 13, 2014

Presentation TVT 2014

Technology Overview and Clinical Trial Status (DEFLECT I and Other Trials)

Presenter: Alexandra J. Lansky

June 06, 2014

Presentation TVT 2014

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

Presenter: Susheel Kodali

June 06, 2014

Presentation TVT 2014

Histo-Pathology Debris Analysis and Status of the MISTRAL C Randomized Trial

Presenter: Nicolas M. van Mieghem

June 06, 2014

Presentation TVT 2014

Technology Overview and Status of the CLEAN-TAVI Randomized Trial

Presenter: Axel Linke

June 06, 2014

Presentation TVT 2014

Technology Overview and Clinical Trial Status (Pilot Phase of PROTAVI C and Beyond)

Presenter: Alec S. Vahanian

June 06, 2014

News Daily News

No Long-term Decline in Cognitive Performance After TAVR

Jason Kahn

October 25, 2013

Presentation TVT 2013

Cerebral Embolic Protection Devices

Presenter: Eberhard Grube

June 14, 2013

News Conference News EuroPCR 2013

Deflection Device Reduces Volume, Not Number, of Cerebral Lesions During TAVR

Jason Kahn

May 24, 2013

News Daily News

Residuos Embólicos Capturados por Filtros en ¾ partes de los Pacientes TAVR

Yael L. Maxwell

May 17, 2013

News Daily News

Embolic Debris Captured by Filters in Three-Quarters of TAVR Patients

Yael L. Maxwell

May 17, 2013

News Daily News

Un Estudio Explora los Predictores y Consecuencias de los ACV tras una TAVR

Caitlin E. Cox

November 18, 2012

Advertisement

As Stroke Rates Fall, Questions Mount for Embolic Protection Devices in TAVR

MISTRAL-C: Cerebral Protection in TAVR May Reduce New Lesions

First US Multi-center Study Finds Unprotected TAVR Procedures Produce New Brain Lesions in Nearly All Cases

Cerebral Embolization Greater When Valvuloplasty Not Done Before TAVR

Mayor Embolización Cerebral Cuando Antes de la TAVR No se realiza una Valvuloplastia

DEFLECT III: 30-Day Results Show Successful, Safe TAVR With Novel Neuroprotection Device

Study Provides Insight Into Cerebral Embolization During TAVR

DEFLECT III: TAVR Neuroprotection Device Safely Reduces Lesion Volume

CLEAN-TAVI: A Prospective, Randomized Trial of Cerebral Embolic Protection in High-Risk Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Technology Overview and Clinical Trial Status (DEFLECT I and Other Trials)

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

Histo-Pathology Debris Analysis and Status of the MISTRAL C Randomized Trial

Technology Overview and Status of the CLEAN-TAVI Randomized Trial

Technology Overview and Clinical Trial Status (Pilot Phase of PROTAVI C and Beyond)

No Long-term Decline in Cognitive Performance After TAVR

Cerebral Embolic Protection Devices

Deflection Device Reduces Volume, Not Number, of Cerebral Lesions During TAVR

Residuos Embólicos Capturados por Filtros en ¾ partes de los Pacientes TAVR

Embolic Debris Captured by Filters in Three-Quarters of TAVR Patients

Un Estudio Explora los Predictores y Consecuencias de los ACV tras una TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content